Henlius.com

Henlius.com has server used 114.215.147.219 (China) ping response time Hosted in Aliyun Computing Co., LTD Register Domain Names at Alibaba Cloud Computing Ltd. d/b/a HiChina (www.net.cn). This domain has been created 13 years, 111 days ago, remaining 1 year, 252 days. You can check the 4 Websites and blacklist ip address on this server

Domain information

Registrar WHOIS Server: grs-whois.hichina.com

Registrar URL: http://wanwang.aliyun.com     See All 0+

Creation Date: 2008-06-26 13 years, 111 days

Updated Date: 2021-08-15 62 days ago

Expiry Date: 2023-06-26 1 year, 252 days left     See All

  Sign up for notifications near expiration

Registrar: Alibaba Cloud Computing Ltd. d/b/a HiChina (www.net.cn)

Abuse Email: [email protected]

Abuse Phone: +86.95187

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email
www.godaddy.com2,280,668GoDaddy.com, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a PublicDomainRegistry.com[email protected]
www.whois.godaddy.com174,077GoDaddy.com, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions

Henlius

Henlius biotech

Henlius pharma

Henlius china

Henlius stock

Henlius stock price

( Please select at least 2 keywords )

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

› Shanghai henlius biotech co ltd

› Shanghai henlius biotech inc

› Shanghai henlius biotech

› Henlius bio

› Henlius stock

› Henlius biotech

› Henlius pharma

› Henlius trastuzumab

Hosting Provider

NetName: ALISOFT

Organization: Aliyun Computing Co., LTD     See All 39,293+

Provider URL: Cnnic.cn

Hostname: 114.215.147.219

IP Server: 114.215.147.219 Reg: , Updated: 2021-06-16T01:30:29Z

Blacklist: Check Backlist Status

Country: China

Address: Beijing, China, CN

Latitude: 30.293600

Longitude: 120.161400

Name Server:

  • DNS25.HICHINA.COM
  • DNS26.HICHINA.COM

Abuse Email: [email protected]

Abuse Phone: +000000000

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,706GoDaddy.com, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

  1: [email protected]

  2: [email protected]

  3: [email protected]

  4: [email protected]

Find Websites hosted

1: Henlius.com

2: Technobezz.com Changed to: 104.26.8.27

3: Home.bt.com Changed to: 68.142.70.29

4: Whatismyip.com Changed to: 104.27.195.88

At least 4 Sites on this server

Port Scanner (IP: 114.215.147.219)

Contact Us-Contact Information

  • 1801 Hongmei Road, Xuhui District, Shanghai Tel

Henlius.com   DA: 15 PA: 28 MOZ Rank: 43

Investor Relations-Contact Information

  • About Henlius Company Profile Corporate Culture Honor Management Team Advisory Board Board of Directors Product Marketed Products Products in R&D Clinical Trial Science & Technology R&D Result R&D Center Technology Platform …

Henlius.com   DA: 15 PA: 31 MOZ Rank: 47

Henlius Biotech Co. Ltd. Email Format Henlius.com Emails

  • uses 1 email formats, with first '_' last (ex
  • [email protected]) being used 100.0% of the time
  • Get Verified Emails for Henlius Biotech Co

Rocketreach.co   DA: 14 PA: 50 MOZ Rank: 66

Contact Us-Privacy

  • Under this Policy, “Personal Information” means any information by which you can be identified, such as your name, birthday, e-mail address, postal address or telephone number
  • Use of Cookies During your visit to this website, an electronic tag (to be more specific, “cookies”) will be placed on your computer’s hard drive for the web

Henlius.com   DA: 15 PA: 27 MOZ Rank: 45

Lexi Zhang's Email & Phone Henlius Biotech Co. Ltd.'s

  • Lexi Zhang's email address l*****@henlius.com | Show email & phone number >>> Rocketreach finds email, phone & social media for 450M+ professionals

Rocketreach.co   DA: 14 PA: 26 MOZ Rank: 44

About Henlius-Company Profile

  • Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases
  • Up to date, 3 products have been launched in China, 1 in the European Union (EU), the New Drug

Henlius.com   DA: 15 PA: 24 MOZ Rank: 44

Product-Products In R&D

  • Henlius adopts a differentiation strategy to initiate the clinical trial of rituximab injection for RA as the indication has not been approved in China, making HLX01-RA the only rituximab filing NDA for RA in China
  • Its NDA was accepted for review by the NMPA in December, 2020.

Henlius.com   DA: 15 PA: 16 MOZ Rank: 37

Henlius Announces Dr. Jean-Michel Gries As President Of

  • Jean-Michel Gries as President of Hengenix
  • Shanghai, China, October 12th, 2021 - Henlius (2696.HK) announced the appointment of Dr
  • Jean-Michel Gries as the president of its affiliation Hengenix Biotech, Inc., based in CA, United States

Henlius.com   DA: 15 PA: 29 MOZ Rank: 51

Shanghai Henlius Biotech

  • Contact Email [email protected]
  • Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services
  • The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters, and novel mAbs using cutting-edge technology
  • The company is a joint venture between Shanghai

Crunchbase.com   DA: 18 PA: 38 MOZ Rank: 64

Henlius Granted Exclusive Development And

  • SHANGHAI, China I September 30, 2020 I Shanghai Henlius Biotech, Inc
  • (2696.HK) announced the Company entered into a collaboration with Accord Healthcare Inc
  • (Accord US), according to which Henlius will grant an exclusive license to Accord US to develop and commercialise HLX02 (trastuzumab biosimilar, Chinese brand name: 汉曲优 ®, EU brand name: Zercepac ®) in the United …

Pipelinereview.com   DA: 18 PA: 50 MOZ Rank: 77

Henlius: Using A Fully Integrated

  • has progressed quickly since it began operating in 2010
  • Today, Henlius is a fully integrated biopharmaceutical company with dozens

Nature.com   DA: 14 PA: 28 MOZ Rank: 52

Henlius Briefing, News, Analysis, Research

  • Henlius, founded in February, 2010 and headquartered in Shanghai, is a medical company involved in tumors and autoimmune diseases
  • Listed on the HKEX on September 25, 2019, the company's major shareholders are Shanghai Fosun New Medicine Research Co., Ltd., Henlius Biopharmaceuticals Inc
  • and Shanghai Fosun Pharmaceutical Industry …

Equalocean.com   DA: 14 PA: 16 MOZ Rank: 41

网易企业邮箱

登录网易企业邮箱,请填写完整的邮件地址或管理员帐号,支持手机扫码登录。用邮箱大师,随时随地,极速收发。

Qiye.163.com   DA: 12 PA: 7 MOZ Rank: 31

Promega And Henlius Developing Microsatellite Instability

  • Shanghai Promega Biological Products Co., Ltd
  • and Shanghai Henlius Biotech, Inc
  • will develop and commercialize a microsatellite instability (MSI) companion diagnostic IVD kit to identify cancer patients likely to benefit from serplulimab, a novel anti-PD-1 monoclonal antibody (mAb) developed by Henlius for the potential treatment of microsatellite instability-high (MSI-H) solid tumors.

Promega.com   DA: 15 PA: 50 MOZ Rank: 78

Ascentage Pharma And Henlius Form A Combination Therapy

SUZHOU, China and ROCKVILLE, Md., November 4, 2019 — Ascentage Pharma(6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced a combination therapy strategic collaboration with Henlius (2696.HK), working together to conduct clinical trials of …

Ascentagepharma.com   DA: 23 PA: 50 MOZ Rank: 87

2021 CSCO Henlius Will Release Four Oral Presentations

  • The 24th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) will be held online and in-person from 25th to 29th September 2021
  • In this meeting, Henlius will release 4 …

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 82

2021 CSCO Henlius Will Release Four Oral Presentations

  • HLX04 is a bevacizumab biosimilar developed by Henlius independently
  • The NDA of HLX04 was accepted by NMPA in September 2020 and is expected to be approved in Q4 2021.

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 84

Henlius: Using A Fully Integrated

  • For more product information, please visitwww.henlius.com Ping Cao, VP of Business Development Henlius Biotech Shanghai, China Tel: +1-510-770-4508 Email: [email protected] CONTACT Fig
  • 1 | The Henlius late-stage clinical pipeline
  • Henlius has progressed rapidly achieving a number of milestones since its formation in 2010.

Media.nature.com   DA: 16 PA: 50 MOZ Rank: 83

Shanghai Henlius Biotech Maps Out Its Biosimilars Future

  • Shanghai Henlius Biotech Maps Out Its Biosimilars Future
  • Shanghai Henlius Biotech began as a 2-person enterprise in 2010 and now has multiple oncology products in development and 3 biosimilars on the market
  • An executive discusses its business trajectory
  • Shanghai Henlius Biotech is one of many companies in China working to crack open the

Centerforbiosimilars.com   DA: 28 PA: 50 MOZ Rank: 96

2021 CSCO Henlius Wird Vier Mündliche Präsentationen Von

In dieser Sitzung wird Henlius 4 Studienergebnisse von 2 Produkten veröffentlichen, die kommerzialisiert werden sollen, dem neuartigen Anti-PD-1-mAb Serplulimab und dem Bevacizumab-Biosimilar HLX04.

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 87

Promega, Henlius To Develop Microsatellite Instability CDx

NEW YORK — Promega said on Thursday that it has signed an agreement to work with Chinese biopharmaceutical firm Henlius Biotech on the development and commercialization of a microsatellite instability, or MSI, companion diagnostic for an investigational cancer drug.

Precisiononcologynews.com   DA: 29 PA: 50 MOZ Rank: 99

2021 CSCO Spoločnosť Henlius Uvedie Na Trh štyri ústne

Na tomto stretnutí spoločnosť Henlius zverejní 4 výsledky štúdie pre 2 produkty, ktoré sa majú komercializovať, nový serplulimab anti-PD-1 mAb a biosimilárny liek bevacizumabu HLX04.

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 89

2021 CSCO Henlius Nabídne čtyři ústní Prezentace Ohledně

Společnost Henlius zde zveřejní výsledky čtyř klinických hodnocení dvou produktů připravených k uvedení na trh, a to nového léčiva anti-PD-1 mAb serplulimab a biosimilárního

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 90

The NDA Of Henlius Novel Anti-PD-1 MAb Serplulimab For

  • 17, 2021 /PRNewswire/ -- Shanghai Henlius Biotech Inc
  • (2696.HK) announced that the New Drug Application (NDA) of Serplulimab Injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with carboplatin and albumin-bound paclitaxel for first-line treatment of locally advanced or metastatic squamous non …

Biospace.com   DA: 16 PA: 50 MOZ Rank: 89

The NDA Of Henlius Novel Anti-PD-1 MAb Serplulimab For

  • 17, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc
  • (2696.HK) announced that the New Drug Application (NDA) of Serplulimab Injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with carboplatin and albumin-bound paclitaxel for first-line treatment of locally advanced or metastatic squamous non …

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 86

Shanghai Henlius Biotech

  • A link to download a PDF version of the drug profile will be included in your email receipt
  • At a glance Originator Shanghai Henlius Biotech Class 22 Jan 2021 Phase-I clinical trials in Colorectal cancer in China (IV) (Shanghai Henlius Biotech pipeline, January 2021)

Adisinsight.springer.com   DA: 24 PA: 16 MOZ Rank: 65

2021 CSCO: Henlius Zaprezentuje Wyniki Czterech Badań Dla

2021 CSCO: Henlius zaprezentuje wyniki czterech badań dla dwóch produktów przewidzianych do komercjalizacji - serplulimabu, nowatorskiego przeciwciała monoklonalnego (mAb) anty-PD-1 oraz

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 94

Henlius Company Profile: Stock

  • Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and innovative biologics for patients with a focus on oncology and autoimmune diseases
  • The company operates in Mainland China and Overseas
  • The company products include HLX01 Rituximab, HLX02 (trastuzumab), and others.

Pitchbook.com   DA: 13 PA: 27 MOZ Rank: 67

2021 CSCO Henlius Will Release Four Oral Presentations

  • In this meeting, Henlius will release 4 study results of 2 products to be commercialized, the novel anti-PD-1 mAb serplulimab and the bevacizumab biosimilar HLX04
  • The study results will all be reported in oral presentations
  • Serplulimab injection is an innovative anti-PD-1 mAb independently developed by Henlius.

Apnews.com   DA: 10 PA: 50 MOZ Rank: 88

Henlius’ Rituximab Results Bolster

  • Henlius Bevacizumab Trials Results Get International Recognition
  • China’s Henlius has received international recognition of Phase I and III clinical trial results for its bevacizumab biosimilar, HLX04, providing “strong evidence for the efficacy and safety similarity between HLX04 and …

Generics.pharmaintelligence.informa.com   DA: 39 PA: 50 MOZ Rank: 21

Recently Analyzed

1: Liveattheparker.com 0 seconds ago

2: Darwinbox.com 0 seconds ago

3: Epm.com 0 seconds ago

4: Justech.com 0 seconds ago

5: Abacuspropertymaintenance.com 0 seconds ago

6: Shalomvillage.ca 0 seconds ago

7: Clubztutoring.com 1 seconds ago

8: Nanoimagingservices.com 1 seconds ago

9: Michianagastro.com 0 seconds ago

10: Exerciseprolive.com 0 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Exerciseprolive.com 119 days leftAmazon Registrar, Inc.Amazon Technologies Inc.
Michianagastro.com 68 days leftMoniker Online Services LLCGoogle LLC
Nanoimagingservices.com5 years, 235 days leftGoogle LLCAmazon Technologies Inc.
Clubztutoring.com 311 days leftNetwork Solutions, LLCAptum Technologies
Shalomvillage.ca1 year, 244 days leftGo Daddy Domains Canada, IncDigitalOcean, LLC
Abacuspropertymaintenance.com 189 days leftGandi SASWeebly, Inc.
Justech.com1 year, 198 days leftAlibaba Cloud Computing (Beijing) Co., Ltd.CHINANET jiangsu province network
Epm.com 344 days leftRegister.com, Inc.Cloudflare, Inc.
Darwinbox.com 42 days leftGoDaddy.com, LLCAmazon Technologies Inc.
Liveattheparker.com 7 days leftGoDaddy.com, LLCAmazon Technologies Inc.

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]